Abstract
Limitation on two dimensional (2D) gel electrophoresis technique causes some proteins to be under presented, especially the extreme acidic, basic, or membrane proteins. To overcome the limitation of 2D electrophoresis, an analysis method was developed for identification of differentially expressed proteins in normal and cancerous colonic tissues using self-pack hydroxyapatite (HA) column. Normal and cancerous colon tissues were homogenized and proteins were extracted using sodium phosphate buffer at pH 6.8. Protein concentration was determined and the proteins were loaded unto the HA column. HA column reduced the complexity of proteins mixture by fractionating the proteins according to their ionic strength. Further protein separation was accomplished by a simple and cost effective sodium dodecyl sulfate–polyacrylamide gel electrophoresis method. The protein bands were subjected to in-gel digestion and protein analysis was performed using electrospray ionization (ESI) ion trap mass spectrometer. There were 17 upregulated proteins and seven downregulated proteins detected with significant differential expression. Some of these proteins were low abundant proteins or proteins with extreme pH that were usually under presented in 2D gel analysis. We have identified brain mitochondrial carrier protein 1, T-cell surface glycoprotein CD1a, SOSS complex subunit B2, and Protein Jade 1 which were previously not detected in 2D gel analysis method.
Similar content being viewed by others
References
Melissa, M. C., Ahmedin, J., Robert, A. S., & Elizabeth, W. (2009). CA: A Cancer Journal for Clinicians, 59, 366–378.
Melissa, M. C., Ahmedin, J., Robert, A. S., & Elizabeth, W. (2009). Cancer Epidemiology, Biomarkers & Prevention, 18, 1688–1694.
Goh, K. L., Quek, K. F., Yeo, G. T. S., Hilmi, I. N., Lee, C. K., Hasnida, N., et al. (2005). Alimentary Pharmacology and Therapeutics, 22, 859–864.
Lee, V. H. L. (2009). Elsevier B V, 61, 1389–1390.
Jain, K. K. (2005). In W. J. LaRochelle & R. A. Shimkets (Eds.), The oncogenomics handbook: proteomics-based anticancer drug discovery (pp. 123–134). New Jersey: Humana.
Srinivas, P. R., Srivastava, S., Hanash, S., & Wright, J. G. L. (2001). Clinical Chemistry, 47, 1901–1911.
Gordon, G. J. (2009). In S. Weinberger & E. Boschetti (Eds.), Bioinformatics in cancer and cancer therapy: proteomics methods in cancer research (pp. 89–114). New Jersey: Humana.
Verma, M. (2009). Methods in Molecular Biology, 471, 197–215.
Gagnon, P. (2009). New Biotechnology, 25, 287–293.
Kibardin, S. A. (1965). Russian Chemical Reviews, 34, 629–637.
Jungbauer, A., Hahn, R., Deinhofer, K., & Luo, P. (2004). Biotechnology and Bioengineering, 87, 364–375.
Process Proteomics Product Note. (2002) Biosepra® HA Ultrogel. Ciphergen.
Gam, L. H., Leow, C. H., Man, C. N., Gooi, B. H., & Singh, M. (2006). World Journal of Gastroenterology, 12, 4973–4980.
Zhou, G., Li, H. M., DeCamp, D., Chen, S., Shu, H., Gong, Y., et al. (2002). Molecular & Cellular Proteomics, 1, 117–124.
Bergh, G. V. D., & Arckens, L. (2004). Current Opinion in Biotechnology, 15, 38–43.
Ciordia, S., Rios, V. D. L., & Albar, J. P. (2006). Clinical Transition Oncology, 8, 566–580.
Lawrie, L. C., Fothergill, J. E., & Murray, G. I. (2001). The Lancet Oncology, 2, 270–277.
Krzysik, A. B., Kang, S. U., Silberrring, J., & Lubec, G. (2006). Journal of Neurochemistry International, 49, 245–255.
Chevalier, F. (2010). Proteome Science., 8, 1–10.
Yeoh, L. C., Loh, C. K., Gooi, B. H., Singh, M., & Gam, L. H. (2010). World Journal of Gastroenterology, 16, 2754–2763.
Dey, A. C., Rahal, S., Rimsay, R. L., & Senciall, I. R. (1981). Analytical Biochemistry, 110, 373–379.
Hjelmeland, L. M. (1990). Methods in Enzymology, 182, 253–264.
Josic, D., & Lim, Y. O. (2001). Food Technology and Biotechnology, 39, 215–226.
Farnum, M., & Zukoski, C. (1999). Biophysical Journal, 76, 2716–2726.
Broadhurst, A. V. (1997). Current protocols in protein Science. United Kingdom: Wiley.
Gagnon, P., Frost, R., Tunon, P. and Ogawa, T. (2009), Tech Note 2156, Bio-Rad
Feki, H. E., Savariault, J. M., & Salah, A. B. (1999). Journal of Alloys and Compounds., 287, 114–120.
Kawasaki, T., Takahashi, S., & Ikeda, K. (1985). European Journal of Biochemistry, 152, 361–371.
Diamantidis, G., Effosse, A., Potier, P., & Bally, R. (2000). Soil Biology & Biochemistry, 32, 919–927.
Bailey, J. L. (1967). Techniques in protein chemistry: column chromatography of proteins. New York: Elsevier.
Yu, X. X., Mao, W., Zhong, A., Schow, P., Brush, J., Sherwood, S. W., et al. (2000). The FASEB Journal, 14, 1611–1618.
Valle, A., Oliver, J., & Roca, P. (2010). Cancers, 2, 567–591.
Huang, J., Gong, Z., Ghosal, G., & Chen, J. (2009). Molecular Cell, 35, 384–393.
Zhao, L., Wang, H., Deng, Y. J., Wang, S., Liu, C., Jin, H., et al. (2009). Modern Pathology, 22, 786–796.
Goebel, H. H. (1995). Muscle & Nerve, 18, 1306–1320.
Yeo, M., Kim, D. L., Park, H. J., Oh, T. Y., Kim, J. H., Cho, S. W., et al. (2006). Proteomics, 6, 1158–1165.
Birkenkamp-Demtroder, K., Olesen, S. H., Sorensen, F. B., Laurberg, S., Laiho, P., Aaltonen, L. A., et al. (2005). Gut, 54, 374–384.
Lin, Y., Buckhaults, P. J., Lee, J. R., Xiong, H., Farrell, C., Podolsky, R. H., et al. (2009). Neoplasia, 11, 864–873.
Briken, V., Jackman, R. M., Watts, G. F., Rogers, R. A., & Porcelli, S. A. (2000). The Journal of Experimental Medicine, 192, 281–288.
Sugita, M., Van, D. W. N., Rogers, R. A., Peters, P. J., & Brenner, M. B. (2000). Proceeding of National Academic Sciences, 97, 8445–8450.
Bedolla, R. G., Wang, Y., Asuncion, A., Chamie, K., Siddiqui, S., Mudryj, M. M., et al. (2009). Clinical Cancer Research, 15, 788–796.
Klaile, E., Muller, M. M., Kannicht, C., Singer, B. B., & Lucka, L. (2005). Journal of Cell Science, 118, 5513–5524.
Yamamoto, S., Tsuda, H., Honda, K., Kita, T., Takano, M., Tamai, S., et al. (2007). Modern Pathology, 20, 1278–1285.
Shao, H., Wang, J. H. C., Pollak, M. R., & Wells, A. (2010). PloS One, 5, e13921.
Yamada, S. I., Yanamoto, S., Yoshida, H., Yoshitomi, I., Kawasaki, G., Mizuno, A., et al. (2010). International Journal of Oral and Maxillofacial Surgery, 39, 61–67.
Kikuchi, S., Honda, K., Tsuda, H., Hiraoka, N., Imoto, I., Kosuge, T., et al. (2008). Clinical Cancer Research, 14, 5348–5356.
Baker, S. G., & Kramer, B. S. (2006). BMC Bioinformatics, 7, 407.
Costa, M. L., Escaleira, R., Cataldo, A., Oliveira, F., & Mermelstein, C. S. (2004). Brazilian Journal of Medical and Bilogical Research, 37, 1819–1830.
Ma, Y. L., Peng, J. Y., Liu, W. J., Zhang, P., Huang, L., Gao, B. B., et al. (2009). Molecular & Cellular Proteomics, 8, 1878–1890.
Pelicano, H., Martin, D. S., Xu, R. H., & Huang, P. (2006). Oncogene, 25, 4633–4646.
Bi, X. Z., Lin, Q. S., Foo, T. W., Joshi, S., You, T., Shen, H. M., et al. (2006). Molecular & Cellular Proteomics, 5, 1119–1130.
Ren, F. L., Wu, H., Lei, Y. L., Zhang, H. Y., Liu, R., Zhao, Y., et al. (2010). Molecular Cancer, 9, 1–17.
Lee, R. A., Kim, H. A., Kang, B. Y., & Kim, K. H. (2006). World Journal of Gastroenterology, 12, 5644–5650.
Kato, G. J. (2009). The Journal of Clinical Investigation, 119, 2140–2142.
Huang, H. L., Stasyk, T., Morandell, S., Dieplinger, H., Falkensammer, G., Griesmacher, A., et al. (2006). Electrophoresis, 7, 1641–1650.
Heys, S. D., Walker, L. G., Deehan, D. I., & Eremin, E. (1998). J.R CoII Surg Edinb, 43, 163–168.
Teramoto, R., Minagawa, H., Honda, M., Miyazaki, K., Tabuse, Y., Kamijo, K. I., et al. (2008). Biochimica et Biophysica Acta, 1784, 764–772.
Myung, J. K., Sadat, L. A., Cabatic, M. F., Slavc, I. and Lubec, G. (2004) Proteome Science. 2.
Fu, H., Subramanian, R. R., & Masters, S. C. (2000). Annual Review Pharmacology and Toxicology, 40, 617–647.
Perathoner, A., Pirkebner, D., Brandacher, G., Spizzo, G., Stadlmann, S., Obrist, P., et al. (2005). Clinical Cancer Research, 11, 3274–3279.
Zhang, Y. B., Ye, Y. J., Shen, D. H., Jiang, K. W., Zhang, H., Sun, W., et al. (2010). Cancer Science, 101, 523–529.
Tzonou, A., Sparos, L., Kalapothaki, V., Zavitsanos, X., Rebelakos, A., & Trichopoulos, D. (1990). British Journal of Cancer, 61, 72–73.
Bhattacharyya, J., & Chaudhuri, L. (1990). Biochemical Medicine and Metabolic Biology, 43, 243–245.
Kataoka, H., Nabeshima, K., Komada, N., & Koono, M. (1989). Virchows Archiv B Cell Pathology, 57, 157–165.
Harris, C. C., Cohen, M. H., Connor, R., Primack, A., Saccomanno, G., & Talamo, R. C. (1976). Cancer, 38, 1655–1657.
Duffy, M. J. (1987). European Journal of Cancer & Clinical Oncology, 23, 583–589.
Acknowledgments
We thank Universiti Sains Malaysia for providing the Research University (RU) grant to carry out and in order to fund this project (Research Universiti Grant, grant no. 1001/PFARMASI/815007) and the Institute of Postgraduate Studies (IPS) for the financial support during the postgraduate study S.-R. Lim. We also want to extend our gratitude to the Ministry of Health in Malaysia for providing tissue specimens for the analysis. Last but not the least, we thank the National Institute of Nutraceutical and Pharmaceutical, Malaysia for their kindness in allowing us to use the LC/MS/MS.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lim, SR., Gooi, BH., Singh, M. et al. Analysis of Differentially Expressed Proteins in Colorectal Cancer Using Hydroxyapatite Column and SDS-PAGE. Appl Biochem Biotechnol 165, 1211–1224 (2011). https://doi.org/10.1007/s12010-011-9339-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-011-9339-3